Arcadia Biosciences (NASDAQ:RKDA) Now Covered by StockNews.com

Investment analysts at StockNews.com started coverage on shares of Arcadia Biosciences (NASDAQ:RKDA) in a report issued on Friday. The firm set a “sell” rating on the basic materials company’s stock.

Arcadia Biosciences Stock Down 10.7 %

Arcadia Biosciences stock opened at $3.46 on Friday. Arcadia Biosciences has a 52-week low of $1.85 and a 52-week high of $10.31. The firm has a market capitalization of $4.72 million, a price-to-earnings ratio of -0.81 and a beta of 0.88. The firm has a 50-day moving average price of $4.91 and a two-hundred day moving average price of $4.07.

Institutional Trading of Arcadia Biosciences

An institutional investor recently bought a new position in Arcadia Biosciences stock. Geode Capital Management LLC purchased a new stake in shares of Arcadia Biosciences, Inc. (NASDAQ:RKDA) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 12,297 shares of the basic materials company’s stock, valued at approximately $73,000. Geode Capital Management LLC owned 0.90% of Arcadia Biosciences as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors own 17.73% of the company’s stock.

About Arcadia Biosciences

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.